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Abstract 
Tissue engineering scaffolds have shown an
intrinsic ability to provide cellular stimulation,
thus behaving as physically active microenvi-
ronments. This study reports on the interac-
tion between human mesenchymal stromal
cells (hMSCs) and dry-wet spun polymer
microfiber meshes. The following scaffolding
parameters were tested: i) polymer type: poly-
L-lactide (PLLA) vs poly-e-caprolactone (PCL);
ii) non-solvent type: ethanol (Et-OH) vs iso-
propanol/gelatin; iii) scaffold layout: patterned
vs random microfiber fabrics. After two culture
weeks, the effects on metabolic activity, scaf-
fold colonization and function of undifferenti-
ated hMSCs were assayed. In our study, the
polymer type affected the hMSC metabolic
activity timeline, and the metabolic picks
occurred earlier in PLLA (day 6) than in PCL
(day 9) scaffolds. Instead, PLLA vs PCL had no
endpoint effect on alkaline phosphatase (ALP)
activity expression. On average, the hMSCs
grown on all the random microfiber fabrics
showed an ALP activity statistically superior to
that detected on patterned microfiber fabrics,
with the highest in Et-OH random subtypes.
Such findings are suggestive of enhanced
osteogenic potential. The understanding of
scaffold-driven stimulation could enable envi-
ronmental hMSC commitment, paving the way
for new regenerative strategies.
Introduction
About two decades ago, tissue engineering
was proposed as an emerging trans-discipli-
nary field to generate three-dimensional (3D)
tissue substitutes ex vivo aimed at accom-
plishing unmet clinical needs and enabling
new regenerative therapies.1 Nowadays, viable
3D cellular constructs have been successfully
obtained in the laboratory by culturing cells
under extrinsic stimulation factors on 3D bio-
material-based scaffolds. These are used to act
as temporary templates for 3D organization
and differentiation of stem cells (SCs), leading
to translational approaches.2,3 Among the adult
SCs, the mesenchymal stem (or stromal) cells
(MSCs) provide a very useful and accessible
cell source and are employed as an effective
tool to obtain several differentiated cellular
types, in particular those deriving from meso-
dermal tissues, such as osteoblasts, chondrob-
lasts, myoblasts and adipoblasts.4 Indeed, mus-
culoskeletal tissues are often affected by
pathologies for which surgical tissue replace-
ments are broadly needed, thus making MSC-
based therapies highly appealing.5 The use of
undifferentiated cells has posed the challenge
of finely tuning and controlling their differen-
tiative profiles; this is usually obtained in vitro
by providing the constructs with chemical (e.g.,
soluble factors) or, more recently, mechanical
(e.g., stresses via fluid dynamics) stimuli
through the culture media (CM).6
Nonetheless, one of the most recent frontiers
in controlling SC behavior is represented by
the application of specific physical stimuli,
inherently induced by the scaffold as a
microenvironment.7 Indeed, interfacing SCs
with defined biomaterial cues (e.g. certain
types of surface topology and material stiff-
ness) has been reported to affect their biology,
thus accrediting the scaffold not only as a
merely passive substrate for cellular organiza-
tion, but rather as an active component of tis-
sue-engineered systems.8
A number of scaffolding technologies have
been developed over the last two decades with
the primary intent of efficiently housing the
cells within proper 3D settings.9 Fiber-based
scaffolds offer highly customizable features,
ranging from nano- to micro-scale, owing to
the many possibilities offered for tailoring
fibers and fabrics.10 Among them, meshes of
ultrafine (<10 μm) fibers produced via electro-
spinning are probably the best investigated in
tissue engineering.11 However, the architectur-
al features and thickness limitations of elec-
trospun scaffolds have restricted their applica-
tions to replace the bi-dimensional defects of
soft connective tissues.12,13 Instead, large diam-
eter (>100 μm) microfiber scaffolds, produced
via 3D printing or other spinning apparatuses,
do not show any limitations of thickness, mak-
ing them true 3D scaffolds. The hollow
microfibers, also referred to as microtubules,
belong to the large-diameter microfiber class
and can be manufactured via dry-wet
spinning.14 This technique exploits ternary (or
multi-) component miscibility to produce
fibers from solutions. Basically, in order to be
spun, the (co)polymer is dissolved inside a sol-
vent (or solvent mixture), while a non-solvent
(or solvent mixture) is concomitantly used to
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obtain the fiber cavity. Upon drying, the wet
fiber solidifies under a ternary (or multi-)
component system, whose miscibility gaps
ultimately tailor the fiber morphology.
Although very appealing in terms of manufac-
turing, the necessity for solvents and non-sol-
vents poses potential cytotoxicity issues for
biomedical use. So far, regenerative opportuni-
ties offered by hollow microfiber scaffolds have
been the subject only of a limited number of
studies.14-19 A decade ago, Lazzeri et al. report-
ed on the fabrication of bioresorbable dry-wet
spunmicrofibers emphasizing their versatility
of incorporating nanoparticle-loaded drugs
useful for tissue engineering applications.14
Later on, Ellis et al. produced microfiber mem-
branes by phase inversion and tested them
using an immortalized osteoblast cell line.
These authors envisioned that hollow
microfiber scaffolds could be interesting bone
substitutes for centimeter-size defects, with
fiber cavities possibly accommodating capillary
and small vasculature infiltration.15 Other in
vitro studies, mostly performed by the authors
of this research, have shown that hollow
microfiber bonded scaffolds were capable of
supporting osteoblast, fibroblast and myoblast
cell lines, as well as primary chondrocytes,
umbilical cord and bone marrow MSCs, thus
appearing widely suitable for musculoskeletal
tissue regeneration.16-19 However, no lineage
specification driven by dry-wet spun scaffolds
has been assessed so far. Recently, some
reports have suggested that other fibrous scaf-
folds can play biomimetic roles on cellular
organization.20,21 The microenvironmental
effects intrinsically induced by the scaffolds
become particularly important when undiffer-
entiated cells, like the SCs, are used, since
topological stimuli can affect, on multi-scale
orders, cell attachment, growth up to differen-
tiation.7,8 Owing to its strategic relevance, the
understanding of scaffold-induced cellular
stimulation deserves additional and systematic
investigative efforts in regenerative therapies.
This study was aimed at fabricating 3D dry-
wet spun microfiber scaffolds for tissue engi-
neering applications. Therefore, the influence
played by polymer, non-solvent and fabric lay-
out upon human MSC (hMSC) culture, was
studied. The poly-L-lactic acid (PLLA) and the
poly-e-caprolactone (PCL), both approved for
clinical practice, were tested as polymers,
while ethanol (Et-OH) and isopropanol/gelatin
(IP-OH/G) water solutions were used as non-
solvents. The obtained hollow microfibers
were assembled either orderly or randomly, so
as to provide different topologic cues for cellu-
lar organization. The investigation of biologi-
cal effects on hMSC behavior possibly caused
by the abovementioned parameters was car-
ried out by assaying metabolic activity, viabili-
ty, 3D organization and expression of alkaline
phosphatase (ALP) activity, the latter as a con-
stitutive marker of these cells that is addition-
ally imputed in their proneness to osteogenic
differentiation.
Insight into fabrication parameters affect-
ing hMSC behavior on microtubule meshes
could enable new knowledge and ultimately
define novel routes to control hMSC fate via
architectural and chemical parameters.
Materials and methods
Materials
For scaffold manufacturing, the following
materials were purchased and used without
modifications: PLLA, Mw≈200,000 and iv=1.4
(Purac Biochem, Gorkum, Netherlands); PCL,
Mn≈80,000 (Sigma-Aldrich, St. Louis, MO,
USA); dichloromethane (Sigma-Aldrich); Et-
OH, 95% vol. and IP-OH, 50% vol. [Carlo Erba
Reagenti, Cornaredo (MI) Italy]; gelatin (G),
CAS Number 9000-70-8 (Merck-Millipore,
Darmstadt, Germany).
For in vitro experiments, the following
materials were purchased and used without
modifications: Lymphoprep (Axis-Shield,
Dundee, UK); low-glucose Dulbecco’s Modified
Eagle Medium (D-MEM), L-glutamine, peni-
cillin-streptomycin, trypsin, phosphate
buffered saline (PBS), trypan blue, neutral red,
methylene blue, P-nitrophenol, 1.5 M 2-amino-
2-methyl-1-propanol, 4-nitrophenyl phosphate
disodium salt hexahydrate, NaOH (all from
Sigma-Aldrich); heat-inactivated fetal bovine
(FBS) (Invitrogen, Carlsbad, CA, USA);
PicoGreen kit (Quant-iTTM; Thermo Fisher
Scientific Inc., Waltham, MA, USA); tissue-cul-
ture polystyrene flasks, and ultra-low attach-
ment (Corning, St. David’s Park, UK); flucona-
zole (Pfizer, New York, NY, USA); absolute Et-
OH (Bio-Optica, Milan, Italy); alamarBlue®
(Serotec Ltd., Kidlington, UK).Scaffold manufacturing
Hollow microfibers of PLLA and PCL were
produced via dry-wet spinning, using a propri-
etary machine (Gimac, Castronno, Italy) locat-
ed at Industrie Biomediche Insubri S/A
(Mezzovico, Switzerland). This is a three-axis
moving apparatus designed to co-spin, via a
computer-controlled motor unit, two solutions
throughout a double-annulus spinneret of sub-
millimeter diameters, thus leading to a contin-
uous hollow microfiber (Figure 1A). 
Specifically, polymer solution and non-sol-
vent solution, placed inside two separate
syringes, converge to the spinneret passing
through the outer and the inner annuli, with
diameters 860 μm and 300 μm, respectively
(Figure 1B). The wet fiber, as generated at its
sprout, is thus collected by a Teflon rotating
drum placed in air environment, designed to
allow evaporation of solvents. The whole proce-
dure is thus considered a dry-wet spinning
process. Indeed, the formation of the
microfiber occurs under a ternary (or multi-)
phase system chemistry, which depends on the
miscibility gaps of the polymer(s), solvent(s),
and non-solvent(s) employed. In this study,
PLLA and PCL were used as polymers, and
dichloromethane as a solvent. Polymers were
dissolved in dichloromethane at 1:3.5 ratio
(w/v). Finally, either Et-OH or IP-OH solution
containing 0.5% (w/v) G were chosen as non-
solvents. The latter non-solvent solution was
obtained by mixing equal volumes of IP-OH
and G aqueous solution, achieved by dissolving
1% (w/v) G in double-distilled water at 50°C
under stirring. After collection, the microfibers
were either orderly or disorderly assembled
into non-woven meshes by means of the fiber
bonding technique, finally giving rise to either
patterned or random fabric layouts. Briefly,
predefined amounts of fibers, as produced by
the dry-wet spinning process, were placed on
Teflon nets and heated, under compression, to
bond the microfibers together via contact
points generated by controlled melting.
Specifically, PLLA and PCL meshes were heat-
ed at 150°C for 1 h and 60°C for about 3 min,
respectively. After bonding, the meshes were
puncher-cut into discs of 15 mm diameter with
about 2 mm thickness.Microfiber and scaffold characteri-zation 
At their sprout from the spinneret, the
microfibers were photographed to assess the
effectiveness of manufacturing. After layout
assembly, the scaffolds were mounted on alu-
minum stumps and sputter-coated with gold
(Sputter Coater Emitech K550; Quorum
Technologies Ltd., Lewes, UK) for 4 min.
Scaffold and fiber morphology was observed
via scanning electron microscopy (SEM)
(Zeiss EVO MA10; Zeiss, Oberkochen,
Germany) under an accelerating voltage of 5-
10 kV. To assess maintenance of hollow mor-
phology in the microfibers after mesh assem-
bly, the scaffolds underwent fracture at -81°C.
The microfiber diameters of the scaffold sur-
faces were measured on serial micrographs
acquired at 100× magnification (n=14).
Finally, the sputter-coated scaffold surfaces
were photographed by means of a camera
equipped for digital macro (Canon Ixus;
Canon, Tokyo, Japan).Isolation and culture of humanmesenchymal stromal cells
HMSCs were isolated from bone marrow
aspirates of patients admitted to our hospital
for orthopedic surgery. Samples were collected
after informed consent, treated anonymously
and in conformity to the principles expressed










[page 10]                                                [Biomedical Science and Engineering 2016; 2:10]
by the Declaration of Helsinki. Briefly, the
bone marrow aspirate was diluted 1:4 in sterile
saline and layered on Lymphoprep as a density
gradient inside sterile tubes. The mononuclear
cell layer, selected via centrifugation at 400×g
for 25 min, was suspended in CM, containing
low-glucose D-MEM, 2 mM L-glutamine, 100
U/mL penicillin, 100 mg/mL streptomycin and
10% (v%) heat-inactivated FBS. The mononu-
clear cells were plated at a density of 0.2·105
cells/cm2 in tissue-culture polystyrene flasks.
After 24 h, hMSCs were purified from other
non-adherent mononuclear cells via washing
with sterile saline. When the cultures reached
about 80% confluence, the hMSCs were
detached by using 0.25% trypsin and replated
at a density of 103 cells/cm2 to allow their
expansion. Cell cultures were carried out in
incubator under standard conditions, namely
37°C, 95% relative humidity, and 5% CO2/95%
air environment. An extensive characteriza-
tion and multi-lineage differentiation capabili-
ty of hMSCs is reported in our previous stud-
ies.22Culture of human mesenchymalstromal cell/scaffold constructs
The microfiber scaffolds (n=4) were steril-
ized by overnight soaking in absolute Et-OH
under ultraviolet irradiation for 1 h. After
washing 10 min with a 3×antibiotics/flucona-
zole solution in sterile saline, the scaffolds
were imbued with FBS for 30 min to favor cell
adhesion. Excess FBS was removed from the
scaffolds before cell seeding. HMSCs were
detached with trypsin, counted under 0.2% try-
pan blue staining for viability evaluation, sus-
pended in 20 μL of CM and seeded on the scaf-
folds at a density of 5×105 viable cells per scaf-
fold. After seeding, the hMSC/scaffold con-
structs were placed in the incubator for 1 h to
permit cell adhesion and were finally covered
with CM at 5 mL/sample inside 6-well plates.
Cell/scaffold constructs were cultured under
standard culture conditions for 16 days, replac-
ing CM every 3 days. Metabolic activity of human mes-enchymal stromal cell/scaffoldconstructs
The metabolic activity of the cells grown on
the scaffolds was monitored along the culture
time using the alamarBlue® assay. This bioas-
say incorporates a REDOX indicator resulting
in color change of the CM according to cell
metabolism. Moreover, it can be performed
multiple times on the same samples on
account of its negligible toxicity. The data were
acquired according to the manufacturer’s
instructions and expressed as percentage of
reduced alamarBlue® (%ABred). Briefly, sam-
ples (n=3) and negative controls (n=3), name-
ly, media plus dye without cells, by using equa-
tion #1 from the manufacturer, were incubated
for 3 h at 37°C with the alamarBlue® dye dilut-
ed in 3 mL of CM for each scaffold, according
to the manufacturer’s recommendations. This
method for calculation against negative con-
trols is useful to assess %ABred increase of the
same samples along a timeline. The total
quantity of dye solution per well was chosen in
theoretical excess, in order to accomplish any
metabolic activity increases all the samples
within 16-day cultures. Indeed, exceeding
100% of dye reduction would affect reaction
kinetics, thus making any comparisons unreli-
able. Viability tests were performed every 3
days after seeding. At each time-point, 100 μL
of supernatant from sample or control was
loaded into 96-well plates; then, excess super-
natant was removed from the cultures and
replaced with fresh CM. The absorbance (l) of
supernatants was measured with a spec-
trophotometer (Victor 3; PerkinElmer,
Waltham, MA, USA) under a double wave-
length reading (570 nm and 600 nm). Finally,
%ABred was calculated by correlating the
absorbance values and the molar extinction
coefficients of the dye at the selected wave-
lengths, following the protocol provided by the
manufacturer. The equation applied (eq. 1) is
shown below, in which, l=absorbance, s=sam-
ple, and c=negative control:
Scaffold colonization by humanmesenchymal stromal cells
Colonization of the scaffold surfaces by
viable hMSCs was qualitatively investigated
using a non-disruptive assay based on Neutral
Red dye, which stains lysosomes of live cells in
red. Briefly, at the endpoint, one specimen per
type (n=1) was incubated with 50 μg/mL CM
solution for 1 h. Samples were rinsed in sterile
PBS and their surface was observed by means
of a camera equipped for digital macro (Canon
Ixus; Canon). 
Methylene Blue is a stain used to visualize
cells against their background, which is useful
to evaluate cell adhesion and colonization on
fixed cell/polymer scaffold specimens. One
MSC/scaffold construct of each type was fixed
in 4% neutral buffered formalin/PBS solution
at 4°C overnight. Samples were rinsed in PBS,
soaked in a 0.05% Methylene Blue solution for
5 min, rinsed with double-distilled water, air-
dried at room temperature. All the stained
samples were observed under 3D digital
microscopy (KH-7700; Hirox-USA,
Hackensack, NJ, USA). 
In addition, one construct per type (n=1)
was processed for SEM analysis. Briefly it was
formalin-fixed dehydrated in a graded series of
ethanol aqueous solutions up to absolute Et-
OH. Thereafter, dehydration of the hMSC/scaf-
fold constructs was completed in a vacuum
oven at 37°C overnight. Samples were mount-
ed on aluminum stubs, sputter-coated with
gold (Emitech K550), and observed via SEM
(Zeiss EVO MA10) under an accelerating volt-
age of 5-10 kV. Micrographs were acquired at
302× magnifications. Construct cellularity
At the endpoint, the double-stranded (ds)
DNA (ds-DNA) content in hMSC/scaffold con-
structs was measured using the PicoGreen
assay. On day 16, the CM was removed from
each construct and replaced with 2 mL of dou-
ble-distilled sterile water. Construct lysates
(n=2) were obtained following two freeze (at -
81°C for 24 h)/thawing (at 37°C for 20 min)
cycles. Thawing was performed in ultrasonic
bath (Falc; Progen Scientific, London, UK) set
at 47 kHz frequency and 20 W output power.
Standard solutions of DNA in double-distilled
water at concentrations ranging in 0-6 μg/mL
were prepared and 50 μL of standard or sample
was loaded in a 96-well black microplate.
Working buffer and PicoGreen dye solutions
were prepared according to the manufacturer’s
instructions and added at 100 and 150 μL per
well, respectively. After a 10-min incubation in
the dark at room temperature, the fluores-
cence intensity of the samples was measured
on a plate reader (Victor3; PerkinElmer),
under an excitation wavelength of 485 nm and
an emission wavelength of 535 nm. Ds-DNA
concentration in cell lysates was thus calculat-
ed against the standard curve. 
                             Article
Table 1. Fiber diameters at the scaffold surfaces. 
                                                      PLLA                                                   PCL
Patterned Et-OH                                    427±101                                                             242±60
Random Et-OH                                         296±88                                                             514±167
Patterned IP-OH/G                                 312±141                                                             544±90
Random IP-OH/G                                    556±245                                                             274±65
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Alkaline phosphatase activity inhuman mesenchymal stromalcell/scaffold constructs
Intracellular ALP activity was evaluated in
cascade on the same construct lysates assayed
for cellularity (n=2) using a colorimetric end-
point assay based on P-nitrophenol. Standards
of P-nitrophenol were prepared in concentra-
tions ranging from 0 to 250 μM. As necessary,
the samples were diluted in double-distilled
water to stay within the detection range of the
assay. Therefore, individual wells of a 96-well
plate were loaded as follows: 80 μL/well of stan-
dard or sample, 20 μL/well of alkaline buffer
solution at pH 10.3 (1.5 M 2-amino-2-methyl-1-
propanol), and 100 μL/well of 4 mg/mL ALP
substrate solution (4-nitrophenyl phosphate
disodium salt hexahydrate in double-distilled
water). The microplate was incubated at 37°C
for 1 h and 100 μL/well of 0.3 M NaOH was
finally added to stop the reaction. The
absorbance was then measured at 405 nm on a
plate reader (Victor3; PerkinElmer). Finally,
ALP activity was normalized by cellularity.Statistical analysis
In hMSC/scaffold constructs, quantitative
data were presented as mean±standard devia-
tion. Differences were investigated by analysis
of variance (ANOVA) with post-hoc t test.
Significance was set at P<0.05. 
Results
Scaffold fabrication and characteri-zation
Using the dry-wet spinning apparatus
shown in Figure 1, hollow microfibers based
on PLLA and PCL were successfully produced
using 96% vol. Et-OH or 50% vol. IP-OH/G solu-
tion as non-solvents (Figure 2A). After produc-
tion, the microfibers showed hollow sections
with main diameters ranging in about 250-500
μm. PLLA microfibers had a larger diameter
and thinner wall (Figure 2 A1-A2) than the PCL
microfibers, which showed a smaller diameter
and thicker wall (Figure 2 A3-A4), independ-
ently of the non-solvent used. Upon scaffold
assembly, the microfibers underwent compres-
sion and heating. Thereafter, the diameters of
microfibers at the scaffold surface were
imaged and measured via SEM. The morpholo-
gy of scaffold layouts and microfibers is shown
in Figures 2B and 3. Micrographs of PLLA are
reported in Figure 3A, while those of PCL in
Figure 3B. For each scaffold type, preservation
of fiber cavities after compression and heating
was confirmed via SEM (Figure 3, lens),
although random PCL scaffolds were the most
altered (Figure 3 B2, lens). Microfiber wall
thickness was measured in a one representa- tive SEM micrograph per sample and ranged in
                                                                                                                    Article
Figure 1. Scheme of the dry-wet spinning system and process: A) 3D drawing showing the
spinning system and its moving axes; B) sketch representing the spinning process and key
components.
Figure 2. Photographs of hollow microfibers and scaffold surfaces. A) Hollow microfibers
at their sprout from the spinneret and further identified by polymer non-solvent couples:
A1) PLLA Et-OH; A2) PLLA IP-OH/G; A3) PCL Et-OH; and A4) PCL IP-OH/G. Scale
bar ¼ mm. B) Photographs of scaffold surfaces sputter coated with gold, obtained via
either random (left column) or ordered (right column) arrangement of microfibers: B1)
PLLA Et-OH; B2) PLLA IP-OH/G; B3) PCL Et-OH; and B4) PCL IP-OH/G. Original
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20-70 μm in PLLA, while 40-90 μm in PCL scaf-
folds.
At their surfaces, orderly assembled scaf-
folds showed tight microfiber bonding, thus
resulting in lower interspaced layouts than
randomly assembled fabrics. In the patterned
scaffolds, the outer microfibers usually had flat
morphology with evidence of intra-fiber melt-
ing and topography artefacts, such as micro-
grooves in PLLA and striping in PCL, probably
imprinted by the Teflon nets during heating
(Figures 3A and B). Differently, randomly
assembled scaffolds showed best-preserved
microfiber topography (Figures 3A and B). PCL
microfibers were more affected by fusion and
flattening induced via the fiber bonding
method than PLLA ones, which, conversely,
could be more easily identified and measured
as single microfibers. Microfiber diameters
measured at the scaffold surfaces are reported
in Table 1. Owing to the artefacts generated by
post-spinning processing, microfiber diame-
ters displayed very broad sizes, ranging from
274±65 μm in IP-OH/G random PCL, to
556±245 μm in IP-OH/G random PLLA. No
apparent trend could be observed among all
the scaffolds subtypes. Human mesenchymal stromal cellcolonization of microfiber meshscaffolds
Using SEM analysis, adherent cells were
found to be layering the microfiber surfaces at
the top surface of all the scaffolds, although
sometimes rarely visible because of their flat
morphology and tight connections forming
homogeneous cell sheets (Figure 4).
Incubation with Neutral Red and staining with
Methylene Blue at the endpoint allowed the
viable cells colonizing the scaffolds to be easily
visualized (Figures 5 and 6). Viable hMSCs
were also detected on the inner microfibers of
the scaffolds, which resulted to be the best col-
onized, as confirmed by the more intense red
color. From a qualitative evaluation, cellular
colonization was most pronounced in IP-OH/G
random and Et-OH random PLLA (Figure 5A),
and in Et-OH random PCL constructs (Figure
5B). Methylene Blue staining performed on
fixed samples allowed an easier handling of
the scaffolds and a better contrast against the
background than those obtained in neutral red
stained samples, so as to enable enhanced
visualization of cells also in the inner layers
(Figure 6).Metabolic activity of human mes-enchymal stromal cell/scaffoldconstructs
The alamarBlue® assay performed at
sequential time-points up to 15 days allowed
hMSC metabolism along the culture time to be
monitored (Figure 7A and B). Under the
applied experimental conditions of this assay,
all the constructs showed initially low metabol-
ic activity ranging from 5.28±0.85% (in PLLA
Et-OH random) to 11.80±0.81% (in PCL Et-OH
random), the latter being the highest with sta-
tistical significance among the hMSC/PCL sub-
types (P<0.05). All the hMSC/PLLA constructs
showed metabolic increases 6 days after seed-
ing, followed by a slow decrease, which was
steadily maintained until the endpoint (Figure
7A). In hMSC/PLLA constructs, the highest
ABred% value averagely detected was
18.03±3.21% in the IP-OH/G random subtype
on day 6, although with no statistical signifi-
cance with respect to other hMSC/PLLA sub-
types. On average, the PLLA IP-OH/G random
constructs had a superior metabolic activity at
any assayed time-point; in particular, it was
the highest among the PLLA constructs from
day 12 until the endpoint (14.62±1.23%,
P<0.05). On the other hand, all the hMSC/PCL
constructs displayed picks in their metabolic
activity on day 9; this was followed by a drop
and a slowly decreasing trend up to the end-
point (Figure 7B). Among PCL constructs, the
highest metabolic activity was found in the Et-
OH random subtype, with statistical signifi-
cance in the PCL series (P<0.05). Additionally,
this value was the highest among all the con-
structs (29.87±5.61%, P<0.05). Finally, the
metabolic activity of hMSC/PCL constructs
ranged from 6.75±0.25% (Et-OH patterned) to
11.10±1.17% (Et-OH random). The latter sub-
type showed an averagely superior metabolic
activity at all assayed time-points. 
                             Article
Figure 3. Scanning electron microscope (SEM) micrographs showing scaffold surfaces at
the endpoint: A) poly-L-lactide (PLLA), and B) poly-ε-caprolactone (PCL). Images are
grouped by non-solvent type and layout sub-type; scale bar=200 μm, 100× magnification.
Lenses show SEM micrographs of hollow microfibers after scaffold fabrication; scale
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Human mesenchymal stromal cellfunction in microfiber mesh scaffolds
Intracellular ALP activity was quantified at
the endpoint to assess cell function and osteo-
differentiative potential on different scaffold
subtypes; ALP values were normalized by cellu-
larity (Figure 7C). ALP activity ranged from
2017±324 μM/(h.μg of ds-DNA) (Et-OH pat-
terned) to 2986±295 μM/(h.μg of ds-DNA) (Et-
OH random) in PLLA scaffold series, while it
ranged from 1887±103 μM/(h.μg of ds-DNA)
(Et-OH patterned) to 3291±483 μM/(h.μg of
ds-DNA) (Et-OH random) in PCL scaffold
series. Considering that the ds-DNA of a
human diploid cell is 7.18 pg/cell, the above
mentioned results mean that, at intracellular
level, single hMSCs produced active ALP
enzyme ranging from 0.226±0.007 nM/min.cell
(Et-OH patterned PCL) to 0.394±0.033
nM/mincell (Et-OH random PCL), which were
averagely the highest and lowest values found
among all the scaffolds subtype. Unpaired t-
student tests were applied to check signifi-
cance between homologous subgroups differ-
ing only according to layout type. Statistical
findings showed that ALP activity values of Et-
OH random were significantly superior to
those of Et-OH patterned subtypes, both for
PLLA (P=0.00029) and PCL (P=0.0000039). No
differences were similarly detected among the
IP-OH/G samples. ANOVA was used to compare
ALP activity under the following variables:
polymer, non-solvent, and layout type.
Differences in ALP activity due to the polymer
type resulted to be non-significant
(F(1,40)=0.30, P=0.585). Differently, both non-
solvent and layout types led to a statistically
significant difference in ALP activity expres-
sion. Specifically, there were statistically sig-
nificant effects of the variables non-solvent
(F(1,40)=8.86, P=0.0049) – being the values of
Et-OH averagely higher than those of the IP-
OH/G subgroups – and layout (F(1,40)=20.25,
P=0.000057) – since the values of random
were averagely higher than those of patterned
subgroups. 
Discussion
Tissue engineering scaffolds have been
invoked to act as cell-conditioning microenvi-
ronments.7,8 This phenomenon has recently
been disclosed as not being a prerogative of
materials provided with ad hoc chemical mod-
ifications. In fact, the chemo-physical features
of the scaffolds have been demonstrated to
enable topological hints which SCs can
respond with behavioral changes.8 Therefore,
the intrinsic stimulations induced by the scaf-
fold offer the intriguing possibility of address-
ing SC differentiation pathways, which is the
subject of innovative researches.8
Due to the limited literature on dry-wet
spun scaffolds, this investigation is very novel
in the tissue-engineering scenario and can be
mainly compared to other fibrous scaffold out-
comes. This study was aimed at identifying
some fabrication parameters in dry-wet spun
microfiber scaffolding, which can affect
hMSCs. In particular, polymer (PLLA vs PCL),
non-solvent (Et-OH vs IP-OH/G), and fabric lay-
out (patterned vs random) were tested as
inherent scaffold features having possible
implications for metabolic activity, 3D colo-
nization, and function of hMSCs. 
Our findings showed that the polymer influ-
enced the metabolic activity timeline of
hMSCs, while microfiber layout enhanced ALP
activity in randomly orientated scaffolds.
Finally, Et-OH as a non-solvent, in combination
with random microfiber assembly, showed the
highest activity values for this enzyme.
Therefore, the obtained results are suggestive
of osteogenic lineage specification induced by
randomly oriented dry-wet spun microfiber
scaffolds, which could disclose possible spill-
overs for bone tissue engineering applications.
The first step of this study consisted in man-
ufacturing hollow microfibers via dry-wet spin-
ning. The main advantages of this scaffolding
technique over other fiber-based methods rely
on the possibility to manufacture polymeric
microfibers exploiting polymer solubility, with-
out having to work from the molten state.16 In
this way, the chemical properties of the poly-
mer are most preserved. There are other spin-
ning techniques used to fabricate fibers from
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Figure 4. Scanning electron microscope micrographs showing human mesenchymal stro-
mal cells (hMSCs) on scaffold surfaces at the endpoint: A) poly-L-lactide (PLLA), and B)
poly-ε-caprolactone (PCL). Images are grouped by non-solvent type and layout sub-type.










polymeric solutions, such as wet-spinning and
electrospinning.12,23,24 However, wet-spun
fibers have reduced possibility for drug incor-
poration if compared to that of dry-wet spun
fibers.14 Finally, unlike electrospun fibers, in
dry-wet spun fibers no theoretical limits exist
to reach the desired thickness.15 In this study,
scaffolds with about 2 mm thickness were
assembled. The methodology reported in this
paper allowed the fabrication of hollow
microfibers based on two bioresorbable FDA-
approved polymers, namely, PLLA and PCL.
Both polymers belong to the linear aliphatic
polyester family, but they display some chemi-
cal differences. For example, the PCL is
remarkably hydrophobic. In particular, PLLA
and PCL greatly differ for their mechanical
properties: PLLA is the stiffest, while PCL is
the most extensible.25 
The mechanical properties of the materials,
such as rigidity, are increasingly recognized as
critical regulators in MSC biology, however,
their mechanism of action has been only par-
tially elucidated.26 It has been reported that, on
stiff surfaces, MSCs enhance tension and
adhesiveness, which is ultimately hypothe-
sized to modulate their lineage specification.7
In our experiments, the polymer type had a
documented effect on the metabolic activity.
Specifically, metabolism vs time curves of
hMSCs growing on same-polymer scaffolds
showed analogous trends. Metabolic raises
occurred at time-points that were earlier in
PLLA (day 6) than in PCL (day 9). In tissue-
engineered constructs, the overall metabolic
activity of cells is a useful tool to encode a
number of biological information, like cytotox-
icity/cytocompatibility, viability and prolifera-
tion. Of the many tests commercially available,
alamarBlue® allows the metabolism of the
same samples to be monitored over time with
good correlation with 3D cellularity, depending
on construct permeability and culture time.27
Specifically, fibrous scaffolds offer open-pore
structures which can overcome metabolite dif-
fusion barriers in 3D constructs.28 In our spec-
imens, ABred% averagely ranged from 5.23% on
day 3 (the lowest value) to 14.62% on day 15
(the highest value). Endpoint results were
qualitatively double-checked with the neutral
red assay, proving the presence and density of
viable cells on the meshes. Within a 2-week
timeframe, the hMSC/scaffold constructs
increased their metabolism at time-points that
were typical for each polymer-groups, showing
values up to 18.03% (PLLA, the highest value
on day 6) and 29.87% (PCL, the highest value
on day 9). From day 9 (PLLA) and 12 (PCL)
onwards, the metabolic activity of the con-
structs reached a plateau, suggesting that that
post-proliferative culture conditions could be
reached.27 Being the cultures carried out con-
comitantly, with identical test specifications
and cellular batch, the trend of the metabolism
curve was attributed to a peculiar influence of
the polymer type on hMSC biochemistry. Both
construct colonization and metabolic activity
resulted best on PLLA IP-OH/G random and
PCL Et-OH random scaffold subtypes, confirm-
ing that, in our scaffolds and time-points, nei-
ther the polymer nor the non-solvent exerted a
preferential role on hMSC metabolism. A dedi-
cated study will be necessary to assess which
properties (e.g., chemical, physical or mechan-
ical) of the polymers are possibly responsible
for this metabolic response.
                             Article
Figure 5. Photographs showing neutral red-stained human mesenchymal stromal cells
(hMSCs)/scaffolds at the endpoint: A) poly-L-lactide (PLLA), and B) poly-ε-caprolactone
(PCL). Main images: magnification 4×, scale bar=1 mm. Lens: digitally zoomed-in micro-
graphs showing cell details, original magnification 35×. 
Figure 6. Stereomicroscopy images showing methylene blue-stained human mesenchymal
stromal cells (hMSCs)/scaffolds at the endpoint: A) poly-L-lactide (PLLA), and B) poly-ε-
caprolactone (PCL). Magnification 50×, scale bar as printed by the microscope 2000 μm. 
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Once the microfibers had been produced
from both polymers, the fiber bonding method
was applied to link them either orderly or ran-
domly as 3D-layered structures. After spinning,
fiber size ranged in 250-500 μm, showing only
qualitative differences between the two poly-
mers. These results are in line with other stud-
ies, reporting dry-wet spun PLA-(co)polymer
microfibers.14-19 The morphological analysis
performed on the scaffold via SEM showed that
the surface microfibers were often flattened,
sometimes melted together and carrying prints
from the grid used during heating, even
though they maintained hollow morphology.
Their average size was inhomogeneous, but it
remained close to that of the fabrication range.
Size differences could not be correlated to any
scaffold parameters chosen for this study. The
only appreciable diversity was that the random
subtypes partially exposed on their surfaces
second layer microfibers, which appeared mor-
phologically preserved. Canha-Gouveia and
colleagues recently showed that hierarchical
features in fibrous scaffolds produced alternat-
ing orderly (3D printed) and random (electro-
spun) fiber layers, and had an osteogenic
effect on SCs derived from Wharton’s jelly.29
In our study, the microfiber arrangement
affected the intracellular ALP activity with
specificity. Many cell types are known to con-
stitutively express ALP under different isoen-
zymes. However, the ALP expression in SCs
has denoted particular implications, according
to their hierarchical potency. For example, the
ALP expression correlated very well with stem-
ness in embryonic-like SCs, while it correlated
with differentiation in adult SCs.30 In adult
hMSCs derived from the bone marrow, ALP has
been recognized as a reliable marker to assess
further bone forming capacity.31 Indeed, the
ALP levels induced by extrinsic cellular stimu-
lation have shown to be predictive for the in
vivo osteogenic differentiation capacity of
these hMSCs. The study of Prins and cowork-
ers defined the significance of this marker by
assaying homogeneous subpopulations of
bone marrow hMSCs, selected from one het-
erogeneous population.31 In our experiments,
the same hMSC batch was equally divided into
all the different scaffold types, each type bro-
ken up into multiple numbers. No differentia-
tive supplements were added in the CM, so
that any significant difference in ALP activity
expression is likely to be the result of a physi-
cal conditioning of the scaffold as a microenvi-
ronment. The detected differences between
ALP activity expressed by hMSCs in patterned
and random scaffolds showed remarkable sta-
tistical significance under the ANOVA test
(P=0.000057), indicating potential for
osteogenic lineage specification driven by ran-
dom layout geometry. According to published
papers, the obtained ALP values are compara-
ble to those of trabecular bone fragments or
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Figure 7. Bar graphs showing the results of quantitative tests: A-B) metabolic activity over
culture time of human mesenchymal stromal cells (hMSCs) grown in poly-L-lactide
(PLLA) and poly-ε-caprolactone (PCL) scaffolds; and C) expression of intracellular alka-
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bone marrow cultured in vitro with  osteogenic
supplements for 15 days, while they are higher
than those usually detected in MSCs or bone
cells grown on culture plastics.32 It is worth
noting that the expression of ALP, like other
markers, results to be frequently increased in
3D-culture systems. 
Finally, some specific influence of the non-
solvent was detected upon ALP activity expres-
sion. The microfibers spun by using Et-OH as a
non-solvent showed, on average, significantly
highly values (P=0.0049) of ALP activity versus
those produced with IP-OH/G. This statistical
difference was less notable than that calculat-
ed by comparing random versus patterned lay-
outs. The combination of random and Et-OH
thus showed the highest ALP activity values. In
this study, two volatile non-solvents, Et-OH and
IP-OH, were used at concentrations that were
chosen to balancing their potential toxicity.33
The microfibers were dried upon collection,
and post-processed in oven, which allowed sol-
vent and non-solvent evaporation. The absence
of cytotoxic effects, as from metabolic and via-
bility assays discussed earlier, corroborated
the effective removal of any toxic components
from the scaffolds and are in line with observa-
tions conducted with dry-wet spun PLLA
(co)polymers.14-19 From a technological stand-
point, the polymer/solvent/non-solvent thermo-
dynamic system determines the miscibility
gaps and the equilibrium phases controlling
the morphological features of the fiber.14,16
Under the applied conditions, phase separa-
tion did not cause fiber nanoporosity. In their
study on spongy scaffolds, Viswanathan and
colleagues highlighted that SC adhesion was
dependent on topology and chemistry, and
independent of porosity. They also showed that
topology, architecture and interconnectivity
affected the SC osteogenic differentiation
potential.8 At this early stage of our investiga-
tion it is not possible to hypothesize any valu-
able reasons explaining the role played by the
non-solvent in these fibrous scaffolds. Only
further studies could ascertain hMSC/random
microfiber scaffold bone formation capacity in
vitro and in vivo and whether the non-solvent
makes a true difference. It can be hypothe-
sized that other physical characteristics of the
materials, such as surface roughness and
hydrophilicity, may affect hMSC behavior. 
Tuning scaffold features intelligently to
address SC fate will enable the development of
smart scaffolds that could catalyze the desired
tissue formation from immature cells, helping
to discourage SC trans-differentiation and tis-
sue overgrowth, which are the actual concerns
of translational therapies.
Conclusions
In this study we investigated the influence
of polymer, non-solvent and scaffold layout of
dry-wet microfiber scaffolds on metabolic
activity, colonization and ALP activity expres-
sion of bone marrow hMSCs. The polymer type
affected the timeline trend of metabolic activi-
ty. Both construct colonization and metabolic
activity resulted to be independent of other
scaffold subtypes. Instead, hMSCs grown on
random microfiber fabrics averagely showed
statistically superior intracellular ALP activity
per cell to that detected on patterned fabrics.
The highest ALP values were detected in the
Et-OH random subtypes. Although the underly-
ing mechanisms of cell-substrate interaction
leading to ALP increase and metabolic behav-
ior still need to be elucidated, the outcomes
reported in this study propose new insights
into fibrous scaffolds like SC conditioning
microenvironments, which could concur to
pave the way for future strategic directions in
SC tissue engineering.
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